MMD has been unsuccessful again in their infringement suit against Camco Engineering and also in their allegation that Camco contravened the Australian Consumer Law.
Pearce IP BioBlast w/e 15 March 2024
15 MAR 2024 | AU | November 2023 PBAC Public Summary Documents Feature Biopharma On 15 March 2024, the Australian Department of Health and Aged Care published the public summary...
Aristocrat down to the felt in the Federal Court on remitter
On 8 March 2024, Justice Burley of the Federal Court issued the latest in a series of decisions relating to the patent-eligibility of Aristocrat’s electronic gaming machine (EGM) patents. Unfortunately it does not resolve the legal uncertainty created by the High Court’s split decision on the matter in 2022. What next?
Leading Light Series: International Women’s Day 2024 | Spotlight on Pearce IP’s Julie Ballance – Special Counsel (NZ)
As a Women Owned and led boutique IP firm, where pay parity is a given, Pearce IP celebrates International Women’s Day and the diversity, equity and inclusion of which we are...
Leading Light Series: International Women’s Day 2024 | Spotlight on Pearce IP’s Jacinta Flattery-O’Brien PhD – Special Counsel
As a Women Owned and led boutique IP firm, where pay parity is a given, Pearce IP celebrates International Women’s Day and the diversity, equity and inclusion of which we are...
Leading Light Series: International Women’s Day 2024 | Spotlight on Pearce IP’s Kim Evans – Executive, Lawyer & Trade Mark Attorney
As a Women Owned and led boutique IP firm, where pay parity is a given, Pearce IP celebrates International Women’s Day and the diversity, equity and inclusion of which we are...
Still stuck in the mud
On 5 March 2024, the Australian Patent Office (APO) issued its decision in the opposition filed by Clearview Towing Mirrors Pty Ltd in respect of Australian patent application AU2020281026 (Opposed Application). Clearview had opposed the grant of the Opposed Application on the grounds of inventive step, novelty, sufficiency, support and clarity.
Leading Light Series: International Women’s Day 2024 | Spotlight on Pearce IP’s Executive Lawyer, Helen Macpherson
As a Women Owned and led boutique IP firm, where pay parity is a given, Pearce IP celebrates International Women’s Day and the diversity, equity and inclusion of which we are...
Leading Light Series: International Women’s Day 2024 | Spotlight on Pearce IP’s Deputy CEO & Head of Talent Adele Chadwick
As a Women Owned and led boutique IP firm, where pay parity is a given, Pearce IP celebrates International Women’s Day and the diversity, equity and inclusion of which we are...
Pearce IP BioBlast w/e 8 March 2024
9 MAR 2024 US | Samsung Bioepis Presents Interchangeability Updates for its Adalimumab and Ustekinumab Biosimilars at AAD On 9 March 2024, Samsung Bioepis presented two papers...
A bet both ways wins PTE for Ono for OPDIVO® (nivolumab) patent based on Merck’s KEYTRUDA® (pembrolizumab)
On 16 February 2024, IP Australia published that Ono Pharmaceutical Co. Ltd (Ono) was granted a patent term extension (PTE) in respect of its Australian Patent No. 2011203119 (Patent). This is the quiet conclusion to Ono’s dispute with the Patent Office relating to OPTIVO® (nivolumab) which culminated in an appeal court decision rejecting its previous application for PTE.
Leading Light Series: International Women’s Day 2024 | Spotlight on Pearce IP’s Founder Naomi Pearce
As a Women Owned and led boutique IP firm, where pay parity is a given, Pearce IP celebrates International Women’s Day and the diversity, equity and inclusion of which we are...
Leading Lights: Celebrating our Female Trailblazers on International Women’s Day 2024
International Women’s Day is a time to celebrate the achievements and progress of women around the world. It’s a day to reflect on the strides we’ve made towards gender equality and inclusion, whilst acknowledging the work that still lies ahead. We take a moment to spotlight some of the incredible women of Pearce IP.
Pearce IP BioBlast w/e 4 March 2024
1 MAR 2024 | AU | Authorities raid Como Compounding Pharmacy in Melbourne and Seize Semaglutide The Australian Financial Review reported that on 1 March 2024 TGA...
The Next Chapter in the Carpark Patent Saga: The Full Court’s Decision on Infringement and Best Method
The Federal Court’s second patent decision of 2024 is a unanimous decision of the Full Federal Court relating to one of several long-running patent disputes in the field of carpark overstay detection. In March 2023, Justice Besanko upheld the validity of two patents owned by Vehicle Monitoring Systems Pty Ltd (VMS), both entitled ‘Method, apparatus and system for parking overstay detection’.
Stuck in the Mud: 4WD storage system patent valid but not infringed
In the first Federal Court patent decision handed down in 2024, MSA 4×4 Accessories Pty Ltd failed to establish infringement by Clearview Towing Mirrors Pty Ltd of MSA’s patent to a mountable storage device, commonly used in off-road and trade vehicles.
Pearce IP BioBlast w/e 23 Feb 2024
23 FEB 2024 | EU | Samsung Bioepis Presented Study Results for ustekinumab SB17, Biosimilar to Janssen’s Stelara®, at ECCO On 23 February 2024, Samsung Bioepis presented two new...
New Head of Legal and Special Counsel join Pearce IP from Big Law
Pearce IP is delighted to welcome Executive Lawyer and Head of Legal Helen Macpherson, and Special Counsel Chantal Savage to its legal team. Helen and Chantal join Pearce IP...
It’s a dog’s life
Zoetis Services LLC opposed two Australian patent applications (one standard and one innovation patent application) in the name of Boehringer Ingelheim Vetmedica GmbH. The applications claim a method of treating heart failure due to asymptomatic myxomatous mitral valve disease (MMVD) in a patient (including a dog) by administering pimobendan (also known as Vetmedin®).
Pearce IP BioBlast w/e 16 Feb 2024
19 JAN 2024 | AU | March a Bumper Month for Biopharma at the Pharmaceutical Benefits Assessment Committee (PBAC) in Australia According to the Pharmaceutical Benefits Assessment...
Pearce IP Welcomes Executive and Head of Trade Marks, Kim Evans
Pearce IP is delighted to welcome Executive Lawyer & Trade Mark Attorney Kim Evans to the team. Kim leads the Pearce IP trade mark team, and joins Pearce IP from Allens...
Pearce IP BioBlast w/e 09 Feb 2024
09 FEB 2024 | AU | Biocon Biologics Enter a Five-year Exclusive Partnership with Sandoz in Australia for Trastuzumab and Bevacizumab Biosimilars On 9 February 2024, Biocon...
Pearce IP BioBlast w/e 02 Feb 2024
2 FEB 2024 | EU | US | Regeneron’s linvoseltamab MAA Filing Accepted by EMA; BLA Submitted to FDA for Multiple Myeloma Regeneron announced that its marketing authorisation...
European Geographical Indications in New Zealand
On 24 January 2024 New Zealand introduced a new IP Bill for Geographical Indications (GIs). The bill will amend NZ law to implement aspects of the Free Trade Agreement with the...
Recent BioBlast® Updates
Get our Pearce IP Blogs & BioBlast® sent directly to your inbox
Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.